Skip to main content
. 2019 Jan 18;9:723. doi: 10.3389/fpsyt.2018.00723

Table 1.

Assessment of each sub-factor of HAMD for PD-D and PD-ND groups.

Frequency (n, %) Score (mean ±SD) Range of the score (min–max)
PD-ND PD-D PD-ND PD-D PD-ND PD-D
Anxiety/somatization 107 (54.60%) 280 (99.30%) 1.08 ± 1.21 4.64 ± 2.48 0–5 0–13
Retardation symptoms 93 (47.40%) 275 (97.51%) 0.69 ± 0.88 3.53 ± 1.86 0–4 0–12
Hopelessness symptoms 89 (45.40%) 253 (89.71%) 0.69 ± 0.90 2.76 ± 1.89 0–4 0–10
Sleep disturbances 60 (30.60%) 211 (74.82%) 0.51 ± 0.96 2.30 ± 1.84 0–5 0–6
Cognitive disturbances 28 (14.30%) 200 (70.92%) 0.14 ± 0.35 1.79 ± 1.95 0–1 0–10
Weight loss 28 (9.20%) 100 (35.46%) 0.12 ± 0.41 0.49 ± 0.73 0–3 0–3
Circadian fluctuations 12 (6.10%) 97(34.40%) 0.10 ± 0.41 0.63 ± 0.97 0–4 0–4